Ginkgo Bioworks
DNA
DNA
179 hedge funds and large institutions have $270M invested in Ginkgo Bioworks in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.95% more ownership
Funds ownership: 64.08% → 67.03% (+2.9%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
38% less capital invested
Capital invested by funds: $437M → $270M (-$167M)
Holders
179
Holding in Top 10
3
Calls
$7.06M
Puts
$2.05M
Top Buyers
| 1 | +$5.83M | |
| 2 | +$4.8M | |
| 3 | +$4.53M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.86M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$2.77M |
Top Sellers
| 1 | -$9.08M | |
| 2 | -$5.02M | |
| 3 | -$2.15M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.47M |
| 5 |
SGDR
SPX Gestao de Recursos
Rio De Janeiro,
Brazil
|
-$1.46M |
